TEAD3 and melanoma: The upregulation of Mmut and the consequent accumulation of methylmalonic acid in high-risk TEAD3 + melanoma cells suggest that targeting these metabolic pathways could disrupt tumor progression mechanisms, particularly in aggressive subtypes such as acral melanoma.